聯系電話:512-67626747 聯系郵箱:eegene215@qq.com
合作廠商登彔/蘇州翊準基因科技有限公司

DPYD, TYMS, TYMP, TK1, AND TK2

發布時間:2017-02-06 ??? 閱讀數:
DPYD, TYMS, TYMP, TK1, and TK2 Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy
 
Ming-Yii Huang,1,2,3 Chan-Han Wu,4 Chun-Ming Huang,1,2
Fu-Yen Chung,4 Ching-Wen Huang,5,6,7 Hsiang-Lin Tsai,3,5,8 Chin-Fan Chen,9
Shiu-Ru Lin,4 and Jaw-Yuan Wang3,5,6,9,10,11
 
Received 6 November 2013; Accepted 22 November 2013
 
Abstract:This study is to investigate multiple chemotherapeutic agent- and radiation-related genetic biomarkers in locally advanced rectal cancer (LARC) patients following fluoropyrimidine-based concurrent chemoradiotherapy (CCRT) for response prediction. We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1

上一篇:SIGNIFICANT OVEREXPRESSION OF DVL1 IN TAIWANESE COLORECTAL C
下一篇:沒有了

  • 蘇州翊準基因科技
    中國江蘇省蘇州市工業園區新平街388號B幢B-203(騰飛創新園塔樓B-203)
    電話:86-512-67626747
    傳真:86-512-67626747
    QQ:2957745965

Copyright © 2016 蘇州翊準基因科技有限公司 版權所有 蘇ICP備17013352號

神马电影午夜dy888-欧美色色-欧美图片_色网站-神马电影午夜dy888